KMT2C, known as lysine methyltransferase 2C or MLL3, is a nuclear protein with the capacity to methylate histone H3 at lysine 4, a modification closely associated with transcriptional regulation. Expressed in a range of tissues, KMT2C has garnered interest for its role in tumor cells. It catalyzes histone methylation, influencing gene expression and participating in cellular proliferation, differentiation, and tumor development. KMT2C's involvement in epigenetic cell regulation and its association with tumorigenesis make it a candidate for cancer therapy targets. Moreover, KMT2C's abnormal expression patterns have been correlated with tumor invasiveness and prognosis.
Recombinant Human Histone-lysine N-methyltransferase 2C (KMT2C), partial
Source: Yeast
Source: E.coli
Source: Baculovirus
Source: Mammalian cell
Source: In Vivo Biotinylation in E.coli
The following KMT2C reagents supplied by CUSABIO are manufactured under a strict quality control system. Multiple applications have been validated and solid technical support is offered.
KMT2C Proteins for Mus musculus (Mouse)
Code | Product Name | Source |
---|---|---|
CSB-YP807397MO CSB-EP807397MO CSB-BP807397MO CSB-MP807397MO CSB-EP807397MO-B |
Recombinant Mouse Histone-lysine N-methyltransferase MLL3 (Mll3), partial | Yeast E.coli Baculovirus Mammalian cell In Vivo Biotinylation in E.coli |
KMT2C Proteins for Homo sapiens (Human)
Code | Product Name | Source |
---|---|---|
CSB-YP822778HU CSB-EP822778HU CSB-BP822778HU CSB-MP822778HU CSB-EP822778HU-B |
Recombinant Human Histone-lysine N-methyltransferase 2C (KMT2C), partial | Yeast E.coli Baculovirus Mammalian cell In Vivo Biotinylation in E.coli |